ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 2.98 $ 0.37 (14.07 %)    

Friday, 21-Nov-2025 15:32:19 EST
QQQ $ 591.62 $ 4.29 (0.73 %)
DIA $ 462.77 $ 3.30 (0.72 %)
SPY $ 659.70 $ 4.71 (0.72 %)
TLT $ 89.46 $ -0.20 (-0.22 %)
GLD $ 373.34 $ -0.65 (-0.17 %)
$ 2.68
$ 2.63
$ 2.81 x 278
$ 2.99 x 11
$ 2.62 - $ 3.00
$ 2.65 - $ 15.82
45,209
na
6.11M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), a specialized digital asset technology comp...

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announce...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investm...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON), a specialized digital asset treasury...

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosy...

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION